ClinicalTrials.gov record
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID: NCT02465515
Public ClinicalTrials.gov record NCT02465515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to treat type 2 diabetes This study will test whether albiglutide affects the occurrence of major cardiovascular events such as heart attacks or strokes and other important medical outcomes in persons with type 2 diabetes, when used alone or added to other diabetes treatments.
Study identification
- NCT ID
- NCT02465515
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 9,463 participants
Conditions and interventions
Conditions
Interventions
- Albiglutide 30 mg Biological
- Albiglutide 50 mg Biological
- Albiglutide matching placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2015 (Actual)
- Primary completion
- Feb 20, 2018 (Actual)
- Completion
- Mar 14, 2018 (Actual)
- Last update posted
- Mar 6, 2019
2015 – 2018
United States locations
- U.S. sites
- 146
- U.S. states
- 36
- U.S. cities
- 128
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35211 | — |
| GSK Investigational Site | Birmingham | Alabama | 35235 | — |
| GSK Investigational Site | Mobile | Alabama | 36608 | — |
| GSK Investigational Site | Chandler | Arizona | 85284 | — |
| GSK Investigational Site | Glendale | Arizona | 85308 | — |
| GSK Investigational Site | Goodyear | Arizona | 85395 | — |
| GSK Investigational Site | Tempe | Arizona | 85283 | — |
| GSK Investigational Site | Tucson | Arizona | 85741 | — |
| GSK Investigational Site | Tucson | Arizona | 85745 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72209 | — |
| GSK Investigational Site | Searcy | Arkansas | 72143 | — |
| GSK Investigational Site | Chula Vista | California | 91910 | — |
| GSK Investigational Site | Lancaster | California | 93534 | — |
| GSK Investigational Site | Lomita | California | 90717 | — |
| GSK Investigational Site | Long Beach | California | 90807 | — |
| GSK Investigational Site | Long Beach | California | 90822 | — |
| GSK Investigational Site | Los Angeles | California | 90017 | — |
| GSK Investigational Site | Los Angeles | California | 90073 | — |
| GSK Investigational Site | Moreno Valley | California | 92555 | — |
| GSK Investigational Site | Northridge | California | 91325 | — |
| GSK Investigational Site | Oakland | California | 94607 | — |
| GSK Investigational Site | San Diego | California | 92103 | — |
| GSK Investigational Site | San Diego | California | 92117 | — |
| GSK Investigational Site | San Marino | California | 91108 | — |
| GSK Investigational Site | San Ramon | California | 94583 | — |
| GSK Investigational Site | Simi Valley | California | 93065 | — |
| GSK Investigational Site | Stanford | California | 94305 | — |
| GSK Investigational Site | Torrance | California | 90502 | — |
| GSK Investigational Site | Denver | Colorado | 80220 | — |
| GSK Investigational Site | Littleton | Colorado | 80120 | — |
| GSK Investigational Site | Littleton | Colorado | 80127 | — |
| GSK Investigational Site | New Haven | Connecticut | 06511 | — |
| GSK Investigational Site | Belle Glade | Florida | 33430 | — |
| GSK Investigational Site | Bradenton | Florida | 34201 | — |
| GSK Investigational Site | Bradenton | Florida | 34209 | — |
| GSK Investigational Site | Coral Gables | Florida | 33134 | — |
| GSK Investigational Site | Coral Springs | Florida | 33065 | — |
| GSK Investigational Site | Fleming Island | Florida | 32003 | — |
| GSK Investigational Site | Inverness | Florida | 34452 | — |
| GSK Investigational Site | Jacksonville | Florida | 32216 | — |
| GSK Investigational Site | Lake Worth | Florida | 33467 | — |
| GSK Investigational Site | Lakeland | Florida | 33805 | — |
| GSK Investigational Site | Miami | Florida | 33174 | — |
| GSK Investigational Site | Ocala | Florida | 34471 | — |
| GSK Investigational Site | Ponte Vedra | Florida | 32081 | — |
| GSK Investigational Site | Port Charlotte | Florida | 33952 | — |
| GSK Investigational Site | Port Orange | Florida | 32127 | — |
| GSK Investigational Site | St. Petersburg | Florida | 33713 | — |
| GSK Investigational Site | Vero Beach | Florida | 32960 | — |
| GSK Investigational Site | Wellington | Florida | 33449 | — |
| GSK Investigational Site | Atlanta | Georgia | 30318 | — |
| GSK Investigational Site | Atlanta | Georgia | 30342 | — |
| GSK Investigational Site | Conyers | Georgia | 30094 | — |
| GSK Investigational Site | Cumming | Georgia | 30041 | — |
| GSK Investigational Site | Decatur | Georgia | 30033 | — |
| GSK Investigational Site | Dunwoody | Georgia | 30338 | — |
| GSK Investigational Site | Snellville | Georgia | 30078 | — |
| GSK Investigational Site | Tucker | Georgia | 30084 | — |
| GSK Investigational Site | Aurora | Illinois | 60504 | — |
| GSK Investigational Site | Champaign | Illinois | 61820 | — |
| GSK Investigational Site | Gurnee | Illinois | 60031 | — |
| GSK Investigational Site | Moline | Illinois | 61265 | — |
| GSK Investigational Site | Avon | Indiana | 46123 | — |
| GSK Investigational Site | Franklin | Indiana | 46131 | — |
| GSK Investigational Site | Greenfield | Indiana | 46140 | — |
| GSK Investigational Site | Muncie | Indiana | 47304- | — |
| GSK Investigational Site | Munster | Indiana | 46321 | — |
| GSK Investigational Site | West Des Moines | Iowa | 50265 | — |
| GSK Investigational Site | Topeka | Kansas | 66606 | — |
| GSK Investigational Site | Lexington | Kentucky | 40503 | — |
| GSK Investigational Site | Louisville | Kentucky | 40213 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70115 | — |
| GSK Investigational Site | Lewiston | Maine | 04240 | — |
| GSK Investigational Site | Annapolis | Maryland | 21401 | — |
| GSK Investigational Site | Saint Cloud | Minnesota | 56303 | — |
| GSK Investigational Site | Saint Paul | Minnesota | 55102 | — |
| GSK Investigational Site | St Louis | Missouri | 63136 | — |
| GSK Investigational Site | Omaha | Nebraska | 68124 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89086 | — |
| GSK Investigational Site | Camden | New Jersey | 08103 | — |
| GSK Investigational Site | Haddon Heights | New Jersey | 08035 | — |
| GSK Investigational Site | Albuquerque | New Mexico | 87102 | — |
| GSK Investigational Site | Brooklyn | New York | 11215 | — |
| GSK Investigational Site | North Massapequa | New York | 11758 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28207 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28209 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28277 | — |
| GSK Investigational Site | Hickory | North Carolina | 28601 | — |
| GSK Investigational Site | Rocky Mount | North Carolina | 27804 | — |
| GSK Investigational Site | Salisbury | North Carolina | 28144 | — |
| GSK Investigational Site | Statesville | North Carolina | 28625 | — |
| GSK Investigational Site | Wilmington | North Carolina | 28401 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| GSK Investigational Site | Fargo | North Dakota | 58103 | — |
| GSK Investigational Site | Cleveland | Ohio | 44122 | — |
| GSK Investigational Site | Columbus | Ohio | 43210 | — |
| GSK Investigational Site | Sandusky | Ohio | 44870 | — |
| GSK Investigational Site | Springfield | Ohio | 45504 | — |
| GSK Investigational Site | Toledo | Ohio | 43614 | — |
| GSK Investigational Site | Camp Hill | Pennsylvania | 17011 | — |
| GSK Investigational Site | Feasterville | Pennsylvania | 19053 | — |
| GSK Investigational Site | Harleysville | Pennsylvania | 19438 | — |
| GSK Investigational Site | Jersey Shore | Pennsylvania | 17740 | — |
| GSK Investigational Site | Lansdale | Pennsylvania | 19446 | — |
| GSK Investigational Site | Newport | Pennsylvania | 17074 | — |
| GSK Investigational Site | Penndel | Pennsylvania | 19047 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15240 | — |
| GSK Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| GSK Investigational Site | Pawtucket | Rhode Island | 02860 | — |
| GSK Investigational Site | Anderson | South Carolina | 29621 | — |
| GSK Investigational Site | Columbia | South Carolina | 29223 | — |
| GSK Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| GSK Investigational Site | Rapid City | South Dakota | 57701 | — |
| GSK Investigational Site | Rapid City | South Dakota | 57702 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Kingsport | Tennessee | 37660 | — |
| GSK Investigational Site | Memphis | Tennessee | 38104 | — |
| GSK Investigational Site | Memphis | Tennessee | 38119 | — |
| GSK Investigational Site | Nashville | Tennessee | 37203 | — |
| GSK Investigational Site | Nashville | Tennessee | 37212 | — |
| GSK Investigational Site | Arlington | Texas | 76014 | — |
| GSK Investigational Site | Austin | Texas | 78731 | — |
| GSK Investigational Site | Bellaire | Texas | 77401 | — |
| GSK Investigational Site | Dallas | Texas | 75216 | — |
| GSK Investigational Site | Dallas | Texas | 75231 | — |
| GSK Investigational Site | Dallas | Texas | 75234 | — |
| GSK Investigational Site | Dallas | Texas | — | — |
| GSK Investigational Site | El Paso | Texas | 79925 | — |
| GSK Investigational Site | Georgetown | Texas | 78626 | — |
| GSK Investigational Site | Houston | Texas | 77070 | — |
| GSK Investigational Site | Huntsville | Texas | 77340 | — |
| GSK Investigational Site | Kingwood | Texas | 77339 | — |
| GSK Investigational Site | Plano | Texas | 75093 | — |
| GSK Investigational Site | San Antonio | Texas | 78229 | — |
| GSK Investigational Site | San Antonio | Texas | 78258 | — |
| GSK Investigational Site | Schertz | Texas | 78154 | — |
| GSK Investigational Site | Suite 101 | Texas | 76132 | — |
| GSK Investigational Site | Tyler | Texas | 75708 | — |
| GSK Investigational Site | Layton | Utah | 84401 | — |
| GSK Investigational Site | Manassas | Virginia | 20109 | — |
| GSK Investigational Site | Federal Way | Washington | 98003 | — |
| GSK Investigational Site | Spokane | Washington | 99208 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
| GSK Investigational Site | Wenatchee | Washington | 98801 | — |
| GSK Investigational Site | Madison | Wisconsin | 53713 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 461 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02465515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2019 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02465515 live on ClinicalTrials.gov.